Indeed, the correlations between CD4+CTLA-4+ T cells and Treg subgroups in circulation of patients with advanced stages could lead to the inhibition of antitumor immunity, which results in a negative outcome in patients with CRC. This evidence concerns the gene CD4 and colorectal carcinoma.